	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	26/02/2020
	www.isa.gov.il			www.tase.co.il				Reference:	2020-02-016660	Time of broadcast: 15:34 15:27:58

Other Report or Announcement

Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

_________

ea119014-424b5_enlivextheASFILED_isa.pdf


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: -1	Date of revision of form structure: 18/02/2020
Address: Einstein 14 , NES-ZIONA 7403618 , ISRAEL Tel: 02-6708072 , Fax: 02-6708070
E-mail address: shachar@enlivexpharm.com Company site: www.enlivex.com

Previous names of reporting entity:

Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: Enlivex thetraputics R&D
Address: Nachal Dan 19 , Qiryat Uno 61580 Telephone: 054-4617610 Facsimile: - E-mail: shachar@ramdor.co.il 2
ISRAEL